Multiorgan Failure
13
3
3
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
1 terminated out of 13 trials
83.3%
-3.2% vs benchmark
8%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study
Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized Trial
MAnual Lymphatic DrAinage to iMprove the outcomE of Patients After Septic Shock
Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis
Hemoperfusion in Critical Patients With Septic Multiorgan Dysfunction Syndrome.
Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia
Metabolites of Tramadol in the Postoperative Surgical Patients
Persistent Multiorgan Failure in Intensive Care Units
The Influence of Nursing Technique Applied at the Central Venous Catheter Insertion Site Upon the Incidence of Infection
NIRS and DO2i Correlation
Intraoperative Dialysis in Liver Transplantation
Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support
Modulation of Systemic Inflammatory Response in Critically Ill Children After Glutamine Supplementation